Helaina prepares to launch human lactoferrin in CPG products following $45 million Series B fundraise
Biotechnology company Helaina is taking the next step in its mission to transform nutrition with human equivalent bioactive proteins by bringing its flagship ingredient – effera Human Lactoferrin – to market in the coming quarter with the help of a $45...